State Of Wyoming Orasure Technologies Inc Transaction History

State Of Wyoming

$676 Million
Q3 2024

A detailed history of State Of Wyoming transactions in Orasure Technologies Inc stock. As of the latest transaction made, State Of Wyoming holds 178,000 shares of OSUR stock, worth $644,360. This represents 0.11% of its overall portfolio holdings.

Number of Shares

178,000

Previous 107,115 66.18%

Holding current value

$644,360

Previous $456,000 66.67%

% of portfolio

0.11%

Previous 0.08%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.93 - $4.59 $278,578 - $325,362	70,885 Added 66.18%	178,000 $760,000
Q2 2024 Aug 14, 2024	SELL	$4.2 - $6.18 $223,406 - $328,726	-53,192 Reduced 33.18%	107,115 $456,000
Q1 2024 May 13, 2024	BUY	$6.08 - $8.28 $218,576 - $297,666	35,950 Added 28.91%	160,307 $985,000
Q4 2023 Feb 14, 2024	BUY	$5.13 - $8.35 $165,083 - $268,703	32,180 Added 34.91%	124,357 $1.02 Million
Q3 2023 Nov 14, 2023	BUY	$4.4 - $6.91 $200,732 - $315,241	45,621 Added 97.99%	92,177 $546,000
Q2 2023 Aug 14, 2023	BUY	$4.88 - $7.39 $129,920 - $196,743	26,623 Added 133.56%	46,556 $233,000
Q1 2023 May 12, 2023	SELL	$4.66 - $6.52 $30,816 - $43,116	-6,613 Reduced 24.91%	19,933 $120,000
Q4 2022 Feb 14, 2023	SELL	$3.7 - $5.29 $72,101 - $103,086	-19,487 Reduced 42.33%	26,546 $127,000
Q3 2022 Nov 14, 2022	BUY	$2.72 - $4.61 $108,745 - $184,307	39,980 Added 660.5%	46,033 $174,000
Q2 2022 Aug 15, 2022	BUY	$2.71 - $7.12 $853 - $2,242	315 Added 5.49%	6,053 $16,000
Q1 2022 May 13, 2022	BUY	$6.62 - $9.33 $16,040 - $22,606	2,423 Added 73.09%	5,738 $39,000
Q4 2021 Feb 11, 2022	BUY	$8.3 - $11.29 $27,514 - $37,426	3,315 New	3,315 $29,000

Others Institutions Holding OSUR

# of Institutions

201

Shares Held

65.4M

Call Options Held

2.2K

Put Options Held

5.1K

View Full List

About ORASURE TECHNOLOGIES INC

Ticker OSUR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 72,619,104
Market Cap $263M
Description
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rap...

More about OSUR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.

Account